Biomarkers in asthma: state of the art

 
Review - Open Access

Abstract

Asthma is a heterogenous disease characterized by multiple phenotypes driven by different mechanisms. The implementation of precision medicine in the management of asthma requires the identification of phenotype-specific markers measurable in biological fluids. To become useful, these biomarkers need to be quantifiable by reliable systems, reproducible in the clinical setting, easy to obtain and cost-effective.

Using biomarkers to predict asthma outcomes and therapeutic response to targeted therapies has a great clinical significance, particularly in severe asthma. In the last years, significant research has been realized in the identification of valid biomarkers for asthma. This review focuses on the existent and emerging biomarkers with clinical higher applicability in the management of asthma.

Download PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: Job vacancy: Paediatric Clinical Research Nurse, Guy's and St Thomas' NHS Foundation Trust, London… https://t.co/kdWOhiMk8D
4hreplyretweetfavorite
Interasma RT @SocLatAlergia: Abierto el plazo para el envío de trabajos libres. https://t.co/3F3ZTY50oR https://t.co/aQSnTdOTSn
7hreplyretweetfavorite
Interasma RT @worldallergy: WISC 2019: You Are Invited to Attend! Registration and Abstract Submission are Now Open https://t.co/YKCvRwdO1j
7hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: Job vacancy: Paediatric Clinical Research Nurse, Guy's and St Thomas' NHS Foundation Trust, London https://t.co/hm
9hreplyretweetfavorite
Interasma RT @Aller_MD: “Researchers identify comprehensive guidelines for managing severe atopic dermatitis” https://t.co/jh5FxCO1QW https://t.co/FS
9hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma